fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Mutual Funds » TATA India PHARMA Healthcare Fund

TATA India PHARMA & Healthcare Fund - G

NAV  ₹26.4455 ↑ 0.14  (0.53 %) as on 14 Jun 24

Scheme Objective

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

TATA India Pharma & Healthcare Fund is a Equity - Sectoral fund launched on 28 Dec 15. It is a fund with High risk and has given a CAGR return of 12.2% since its launch.  Return for 2023 was 36.6% , 2022 was -8% and 2021 was 19.1% .

Below is the key information for TATA India Pharma & Healthcare Fund

NAV as on 14 Jun 24₹26.4455 ↑ 0.14  (0.53 %)
Net Assets (AUM) as on 30 Apr 2024 ₹894 Cr.
Launch Date28 Dec 2015
CategoryEquity - Sectoral
RatingNot Rated
TypeOpen Ended Fund
RiskHigh
AMCTata Asset Management Limited
Alpha Ratio4.23
Expense Ratio2.13 %
Sharpe Ratio2.493
Information Ratio0.69
BenchmarkNot Available
Min Investment ₹5,000
Min SIP Investment ₹150
Exit Load 0-3 Months (0.25%),3 Months and above(NIL)

Returns

Annual Compounded Returns

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 14 Jun 24

DurationReturns
1 Month 5.2%
3 Month 7.5%
6 Month 21.3%
1 Year 52%
3 Year 15.6%
5 Year 25.2%
10 Year
15 Year
Since launch 12.2%

Historical Annual Returns

Historical performance (Yearly) on absolute basis

YearReturns
2023 36.6%
2022 -8%
2021 19.1%
2020 64.4%
2019 5.5%
2018 -2.6%
2017 4.7%
2016 -14.7%
2015

Growth of 10k Over Years

DateValue
31 May 19₹10,000
31 May 20₹12,715
31 May 21₹18,943
31 May 22₹18,140
31 May 23₹19,370
31 May 24₹28,618
TATA India PHARMA & Healthcare Fund Growth 10k Chart

Asset Allocation

Asset ClassValue
Cash2.31%
Equity97.69%
TATA India PHARMA & Healthcare Fund Asset Allocation

Sector Allocation

SectorValue
Health Care95.7%
Basic Materials1.99%
TATA India PHARMA & Healthcare Fund Equity Allocation

Top Securities Holdings / Portfolio

Holdings/Securities

NameGlobal IndustryHoldingValueQuantity
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMA
Drug Manufacturers - Specialty & Generic14%₹121 Cr804,300
↑ 15,000
Aurobindo Pharma Ltd (Healthcare)
Equity, Since 30 Apr 20 | AUROPHARMA
Drug Manufacturers - Specialty & Generic10%₹85 Cr741,000
↑ 25,000
Lupin Ltd (Healthcare)
Equity, Since 30 Nov 17 | 500257
Drug Manufacturers - Specialty & Generic9%₹84 Cr510,240
Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 18 | DRREDDY
Drug Manufacturers - Specialty & Generic7%₹67 Cr107,643
↑ 35,136
Cipla Ltd (Healthcare)
Equity, Since 30 Apr 20 | 500087
Drug Manufacturers - General7%₹58 Cr415,000
Zydus Lifesciences Ltd (Healthcare)
Equity, Since 31 Dec 22 | 532321
Drug Manufacturers - Specialty & Generic5%₹45 Cr471,287
Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB
Drug Manufacturers - Specialty & Generic5%₹42 Cr104,965
Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Oct 20 | 532843
Medical Care Facilities4%₹38 Cr855,100
Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Dec 16 | APOLLOHOSP
Medical Care Facilities4%₹35 Cr58,903
Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 20 | ALKEM
Drug Manufacturers - Specialty & Generic4%₹34 Cr70,249
↑ 2,200
1 - 10 of 33
Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Fund Managers

NameSinceTenure
Meeta Shetty9 Mar 213.15 Yr.

Custodians

CompanyAddress
Deutsche Bank AGDeutsche Bank AG,Kodak House, 22, D.N. Road,

Registrar & Transfer Agent

Computer Age Management Services Ltd
AddressNew No.10, Old No.178,,Kodambakkam High Road,,Opp. Hotel Palmgrove,,Nungambakkam
FAX91-44-28283610
Emailenq_L@camsonline.com

Administrator Companies

CompanyAddress
Tata Mutual Fund1903, B-Wing, Parinee Crescenzo,,G-Block, Bandra Kurla Complex, Bandra East Mumbai 400051

Auditors

CompanyAddress
Deloitte Haskins & Sells LLP12, Dr. Annie Besant Road, Opp. Shiv Sagar Estate,,Worli
M/s BSR & Co.KPMG House, Kamala Mills Compound,448 Senapati Bapat Marg,Lower Parel

All Plan & Options

Fund and PlanNAV6 Month1 Year3 Year5 Year
TATA India Pharma & Healthcare Fund
Normal Dividend, Reinvestment
₹26.4455
↑ 0.14
21.34 %51.96 %15.56 %25.17 %
TATA India Pharma & Healthcare Fund
Normal Dividend, Payout
₹26.4455
↑ 0.14
21.34 %51.96 %15.56 %25.17 %
TATA India Pharma & Healthcare Fund
Growth
₹26.4455
↑ 0.14
21.34 %51.96 %15.56 %25.17 %
Data as on 14 Jun 24

Disclaimer:
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data.